Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | 227,984 | reported | 22 Dec 2021 | tx 519+4,145,563−3,613,534 |
| PROKIDNEY CORP. | 48,128 | reported | 29 Jun 2023 | tx 3+1,276,154 |
| Hemab Therapeutics Holdings, Inc. | 35,948 | reported | 04 May 2026 | tx 5+143,286−1,634 |
| Beam Therapeutics Inc. | 33,662 | reported | 04 Jun 2025 | tx 5+96,832 |
| AGIOS PHARMACEUTICALS, INC. | 28,528 | reported | 20 Sept 2022 | tx 38+142,797−49,421 |
| Rapport Therapeutics, Inc. | 21,850 | reported | 17 Jun 2025 | tx 1+21,850 |
| Kymera Therapeutics, Inc. | 16,000 | reported | 25 Jun 2025 | tx 4+68,000 |
| bluebird bio, Inc. | 5,843 | reported | 14 Sept 2017 | tx 23+109,546−61,835 |
| Regulus Therapeutics Inc. | 0 | reported | 10 Oct 2012 | tx 2+6,150,500−6,150,500 |
2 purchases reported after at least 12 months of silence — most recent on 24 Jul 2013.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 May 2026 | CONVERSION | Hemab Therapeutics Holdings, Inc. | 17,974 | — | |
| 04 May 2026 | CONVERSION | Hemab Therapeutics Holdings, Inc. | 17,974 | — | |
| 29 Jan 2026 | GRANT_AWARD | Hemab Therapeutics Holdings, Inc. | 107,338 | 0.00 USD | deriv |
| 04 May 2026 | CONVERSION | Hemab Therapeutics Holdings, Inc. | 817 | 0.00 USD | deriv |
| 04 May 2026 | CONVERSION | Hemab Therapeutics Holdings, Inc. | 817 | 0.00 USD | deriv |
| 25 Jun 2025 | GRANT_AWARD | Kymera Therapeutics, Inc. | 16,000 | 0.00 USD | deriv |
| 17 Jun 2025 | GRANT_AWARD | Rapport Therapeutics, Inc. | 21,850 | 0.00 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | Beam Therapeutics Inc. | 33,662 | 0.00 USD | deriv |
| 18 Jun 2024 | GRANT_AWARD | Kymera Therapeutics, Inc. | 16,000 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Beam Therapeutics Inc. | 23,114 | 0.00 USD | deriv |
| 29 Jun 2023 | GRANT_AWARD | PROKIDNEY CORP. | 48,128 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | Kymera Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
| 06 Jun 2023 | GRANT_AWARD | Beam Therapeutics Inc. | 16,532 | 0.00 USD | deriv |
| 20 Sept 2022 | GIFT | AGIOS PHARMACEUTICALS, INC. | 1,500 | 0.00 USD | |
| 01 Sept 2022 | GRANT_AWARD | Beam Therapeutics Inc. | 10,391 | 0.00 USD | deriv |
| 11 Jul 2022 | GRANT_AWARD | PROKIDNEY CORP. | 614,013 | 0.00 USD | deriv |
| 11 Jul 2022 | GRANT_AWARD | PROKIDNEY CORP. | 614,013 | 0.00 USD | deriv |
| 21 Jun 2022 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 29,307 | 0.00 USD | deriv |
| 21 Jun 2022 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 4,975 | 0.00 USD | deriv |
| 20 May 2022 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 1,585 | 0.00 USD | |
| 20 May 2022 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 1,585 | 0.00 USD | deriv |
| 18 Jan 2022 | GRANT_AWARD | Kymera Therapeutics, Inc. | 24,000 | 0.00 USD | deriv |
| 22 Dec 2021 | TAX_WITHHOLDING | ALNYLAM PHARMACEUTICALS, INC. | 6,315 | 189.13 USD | |
| 21 Dec 2021 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 14,167 | 0.00 USD | |
| 22 Dec 2021 | TAX_WITHHOLDING | ALNYLAM PHARMACEUTICALS, INC. | 319 | 186.02 USD |